接受保留生育功能手术治疗的上皮性卵巢癌患者的生存情况
这项丹麦全国回顾性研究纳入2005至2016年间年龄≤45岁、FIGO分期≤IC3的上皮性卵巢癌患者106例,其中13例接受保留生育功能手术(FSS),93例接受根治性手术(RS)。FSS组总生存率为100%,RS组为87%,两组总生存无显著差异;疾病特异性生存率FSS组为100%,RS组为91%。作者结论认为FIGO I期患者接受FSS与RS相比生存未受损,但因患者数量有限及研究回顾性性质需谨慎解读,需更大规模研究。
要点
- 丹麦全国回顾性研究纳入106例≤45岁、FIGO≤IC3上皮性卵巢癌患者,FSS组13例,RS组93例。
- FSS组总生存率100%,RS组87%,两组总生存无显著差异。
- FSS组疾病特异性生存率100%,RS组91%。
核心结论
- 作者认为,FIGO I期上皮性卵巢癌患者接受FSS与接受RS相比生存未受损。
- 作者指出,该结论因患者数量有限及研究回顾性性质需谨慎解读,需更大规模研究后方可得出结论。
研究设计与样本
- 研究为丹麦全国回顾性研究,评估2005至2016年间年龄≤45岁、FIGO分期≤IC3的上皮性卵巢癌患者中FSS与RS的效果。
- 共纳入106例患者,其中13例接受FSS,93例接受RS。
- FSS组中位年龄27岁,RS组中位年龄42岁(P < 0.0001)。
主要发现
- 两组总生存无显著差异。
- FSS组总生存率为100%,RS组总生存率为87%。
- FSS组疾病特异性生存率为100%,RS组疾病特异性生存率为91%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 患者数量有限。
- 研究为回顾性研究。
- 需更大规模研究后方可得出结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: How many patients in Denmark were treated with fertility-sparing surgery (FSS) for epithelial ovarian cancer (EOC) and what was their prognosis compared with patients treated with radical surgery (RS)? DESIGN: This study was a retrospective Danish nationwide study, evaluating the effect of FSS compared with RS in patients with EOC, age ≤45 years and International Federation of Gynecology and Obstetrics (FIGO) stage ≤IC3 from 2005 to 2016. RESULTS: A total of 106 patients were included. Of these, 13 were treated with FSS and 93 were treated with RS. Median age was 27 versus 42 years (P < 0.0001). Overall survival did not differ significantly between the two groups. Overall survival rate in the FSS group was 100%, while the overall survival in the RS group was 87%. Disease-specific survival was 100% in the FSS group and 91% in the RS group. CONCLUSIONS: This study shows that patients treated with FSS for FIGO stage I EOC do not have an impaired survival compared with patients treated with RS. Nevertheless, the conclusion must be interpreted with caution due to the limited number of patients and the retrospective nature of the study. Larger studies are needed before conclusions can be drawn.
引用
- Hedbäck NE, Karlsen MA, Høgdall CK, et al. Survival of selected patients with ovarian cancer treated with fertility-sparing surgery. Reprod Biomed Online. 2018. PMID: 29685481. doi:10.1016/j.rbmo.2018.03.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。